Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

被引:0
|
作者
Xia Qin
Jian Zhang
Yu Lin
Xue-ming Sun
Jia-ning Zhang
Zhi-qiang Cheng
机构
[1] Qilu Hospital of Shandong University,Department of General Surgery
[2] The Graduate School of Second Military Medical University,Department of Thoracic Surgery
[3] Shandong Cancer Hospital and Institute,School of Medicine and Life Sciences
[4] Shandong First Medical University and Shandong Academy of Medical Sciences,Department of Neonatology
[5] University of Jinan,The Third Department of Hepatic Surgery
[6] Shandong Academy of Medical Sciences,undefined
[7] The Graduate School of Fujian Medical University,undefined
[8] Yidu Central Hospital of Weifang,undefined
[9] Eastern Hepatobiliary Surgery Hospital,undefined
关键词
MicroRNA-211-5p; ACSL4; Hepatocellular carcinoma; Tumorigenesis; Migration; Invasion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] miR-211-5p is down-regulated and a prognostic marker in bladder cancer
    Wang, Weisheng
    Liu, Zhiming
    Zhang, Xuegang
    Liu, Junning
    Gui, Junqing
    Cui, Maorong
    Li, Yong
    [J]. JOURNAL OF GENE MEDICINE, 2020, 22 (12):
  • [32] The miRNAs miR-211-5p and miR-204-5p modulate ER stress in human beta cells
    Grieco, Fabio Arturo
    Schiavo, Andrea Alex
    Brozzi, Flora
    Juan-Mateu, Jonas
    Bugliani, Marco
    Marchetti, Piero
    Eizirik, Decio L.
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2019, 63 (02) : 139 - 149
  • [33] Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis
    Sun, Xiao-Jie
    Xu, Ge-Liang
    [J]. MEDICAL SCIENCE MONITOR, 2017, 23 : 4343 - 4350
  • [34] miR-202 functions as a tumor suppressor in hepatocellular carcinoma by targeting HK2
    Wang, Jiangang
    Chen, Jili
    Sun, Fang
    Wang, Zhiwei
    Xu, Wenfang
    Yu, Yafeng
    Ding, Feng
    Shen, Huajiang
    [J]. ONCOLOGY LETTERS, 2020, 19 (03) : 2265 - 2271
  • [35] RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4
    Wang, Chun
    Chen, Zhihang
    Yi, Yun
    Ding, Yang
    Xu, Fei
    Kang, Hui
    Lin, Kun
    Shu, Xiawen
    Zhong, Zibiao
    Zhang, Zhonglin
    Liu, Jing
    Xu, Zhong
    Liu, Lan
    He, Xingxing
    Chang, Ying
    Zhao, Qiu
    [J]. ONCOGENE, 2024, 43 (05) : 328 - 340
  • [36] Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
    Lu, Yuanjun
    Chan, Yau-Tuen
    Tan, Hor-Yue
    Zhang, Cheng
    Guo, Wei
    Xu, Yu
    Sharma, Rakesh
    Chen, Zhe-Sheng
    Zheng, Yi-Chao
    Wang, Ning
    Feng, Yibin
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [37] ZNF8-miR-552-5p Axis Modulates ACSL4-Mediated Ferroptosis in Hepatocellular Carcinoma
    Yang, Hao
    Sun, Wensheng
    Bi, Tao
    Sun, Jiahao
    Lu, Zhihua
    Li, Jie
    Wei, Honglong
    [J]. DNA AND CELL BIOLOGY, 2023, 42 (06) : 336 - 347
  • [38] Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
    Yuanjun Lu
    Yau-Tuen Chan
    Hor-Yue Tan
    Cheng Zhang
    Wei Guo
    Yu Xu
    Rakesh Sharma
    Zhe-Sheng Chen
    Yi-Chao Zheng
    Ning Wang
    Yibin Feng
    [J]. Journal of Experimental & Clinical Cancer Research, 41
  • [39] RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4
    Chun Wang
    Zhihang Chen
    Yun Yi
    Yang Ding
    Fei Xu
    Hui Kang
    Kun Lin
    Xiawen Shu
    Zibiao Zhong
    Zhonglin Zhang
    Jing Liu
    Zhong Xu
    Lan Liu
    Xingxing He
    Ying Chang
    Qiu Zhao
    [J]. Oncogene, 2024, 43 : 328 - 340
  • [40] CircCDYL Acts as a Tumor Suppressor in Wilms' Tumor by Targeting miR-145-5p
    Zhou, Rui
    Jia, Wei
    Gao, Xiaofeng
    Deng, Fuming
    Fu, Kai
    Zhao, Tianxin
    Li, Zhongmin
    Fu, Wen
    Liu, Guochang
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9